Incidentally discovered medullary thyroid cancer: Diagnostic strategies and treatment

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 5, 2011, Pages 1237-1245

  Ahmed, Shabina R ^a   Ball, Douglas W ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CARCINOEMBRYONIC ANTIGEN; PENTAGASTRIN; PROTEIN RET; BIOLOGICAL MARKER;

ASPIRATION BIOPSY; CALCITONIN BLOOD LEVEL; CELL PROLIFERATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; GENE MUTATION; HUMAN; HYPERPARATHYROIDISM; LYMPH NODE DISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT MEDULLARY THYROID CARCINOMA; PHEOCHROMOCYTOMA; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SYSTEMATIC REVIEW; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; TUMOR VOLUME; BLOOD; INCIDENTAL FINDING; MEDULLARY CARCINOMA; NEEDLE BIOPSY; THYROID TUMOR; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; BIOPSY, FINE-NEEDLE; CALCITONIN; CARCINOMA, MEDULLARY; HUMANS; INCIDENTAL FINDINGS; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 79955662436     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-2359     Document Type: Review

References (54)

1. Machens A, Niccoli-Sire P, Hoegel J, Frank-Raue K, van Vroonhoven TJ, Roeher HD, Wahl RA, Lamesch P, Raue F, Conte-Devolx B, Dralle H 2003 Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 349:1517-1525 (Pubitemid 37255037)
2. O'Riordan JA 1997 Pheochromocytomas and anesthesia. Int Anesthesiol Clin 35:99-127 (Pubitemid 28044740)
3. Eisenhofer G, Rivers G, Rosas AL, Quezado Z, Manger WM, Pacak K 2007 Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management. Drug Saf 30:1031-1062 (Pubitemid 350036603)
4. Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schlumberger M, Wells Jr SA 2009 Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 19:565-612
5. Lundgren CI, Delbridg L, Learoyd D, Robinson B 2007 Surgical approach to medullary thyroid cancer. Arq Bras Endocrinol Metabol 51:818-824
6. Cohen MS, Moley JF 2003 Surgical treatment of medullary thyroid carcinoma. J Intern Med 253:616-626 (Pubitemid 36649093)
7. Machens A, Dralle H 2010 Biomarker-based risk stratification for previously untreated medullary thyroid cancer. J Clin Endocrinol Metab 95:2655-2663
8. Ball DW 2009 American Thyroid Association guidelines for management of medullary thyroid cancer: an adult endocrinology perspective. Thyroid 19:547-550
9. Jo VY, Stelow EB, Dustin SM, Hanley KZ 2010 Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol 134:450-456
10. Roman S, Lin R, Sosa JA 2006 Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases. Cancer 107:2134-2142 (Pubitemid 44665646)
11. Biscolla RP, Ugolini C, Sculli M, Bottici V, Castagna MG, Romei C, Cosci B, Molinaro E, Faviana P, Basolo F, Miccoli P, Pacini F, Pinchera A, Elisei R 2004 Medullary and papillary tumors are frequently associated in the same thyroid gland without evidence of reciprocal influence in their biologic behavior. Thyroid 14:946-952 (Pubitemid 39612913)
12. Kim WG, Gong G, Kim EY, Kim TY, Hong SJ, Bae Kim W, Shong YK 2010 Concurrent occurrence of medullary thyroid carcinoma and papillary thyroid carcinoma in the same thyroid should be considered as coincidental. Clin Endocrinol (Oxf) 72:256-263
13. Chao TC, Lin JD, Chen MF 2004 Surgical treatment of thyroid cancers with concurrent Graves disease. Ann Surg Oncol 11:407-412
14. Valle LA, Kloos RT 2011 The prevalence of occult medullary thyroid carcinoma at autopsy. J Clin Endocrinol Metab 96:E109-E113
15. Wohllk N, Cote GJ, BugalhoMM,Ordonez N, Evans DB, Goepfert H, Khorana S, Schultz P, Richards CS, Gagel RF 1996 Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 81:3740-3745 (Pubitemid 26339948)
16. Kebebew E, Ituarte PH, Siperstein AE, Duh QY, Clark OH 2000 Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 88:1139-1148 (Pubitemid 30127676)
17. Kim SH, Kim BS, Jung SL, Lee JW, Yang PS, Kang BJ, Lim HW, Kim JY, Whang IY, Kwon HS, Jung CK 2009 Ultrasonographic findings of medullary thyroid carcinoma: a comparison with papillary thyroid carcinoma. Korean J Radiol 10:101-105
18. Lee S, Shin JH, Han BK, Ko EY 2010 Medullary thyroid carcinoma: comparison with papillary thyroid carcinoma and application of current sonographic criteria. AJR Am J Roentgenol 194:1090-1094
19. Hong Y, Liu X, Li Z, Zhang X, Chen M, Luo Z 2009 Real-time ultrasound elastography in the differential diagnosis of benign and malignant thyroid nodules. J Ultrasound Med 28:861-867
20. Sebag F, Vaillant-Lombard J, Berbis J, Griset V, Henry JF, Petit P, Oliver C 2010 Shear wave elastography: a new ultrasound imaging mode for the differential diagnosis of benign and malignant thyroid nodules. J Clin Endocrinol Metab 95:5281-5288
21. Papaparaskeva K, Nagel H, Droese M 2000 Cytologic diagnosis of medullary carcinoma of the thyroid gland. Diagn Cytopathol 22: 351-358 (Pubitemid 30396793)
22. Tee YY, Lowe AJ, Brand CA, Judson RT 2007 Fine-needle aspiration may miss a third of all malignancy in palpable thyroid nodules: a comprehensive literature review. Ann Surg 246:714-720 (Pubitemid 350035645)
23. Ravetto C, Colombo L, Dottorini ME 2000 Usefulness of fine-needle aspiration in the diagnosis of thyroid carcinoma: a retrospective study in 37,895 patients. Cancer 90:357-363 (Pubitemid 32011847)
24. Caraway NP, Sneige N, Samaan NA 1993 Diagnostic pitfalls in thyroid fine-needle aspiration: a review of 394 cases. Diagn Cytopathol 9:345-350 (Pubitemid 23155821)
25. Niccoli P, Wion-Barbot N, Caron P, Henry JF, de Micco C, Saint Andre JP, Bigorgne JC, Modigliani E, Conte-Devolx B 1997 Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group. J Clin Endocrinol Metab 82:338-341 (Pubitemid 27068587)
26. Elisei R, Bottici V, Luchetti F, Di Coscio G,RomeiC, Grasso L, Miccoli P, Iacconi P, Basolo F, Pinchera A, Pacini F 2004 Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 89:163-168 (Pubitemid 38183876)
27. Cheung K, Roman SA, Wang TS, Walker HD, Sosa JA 2008 Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis. J Clin Endocrinol Metab 93:2173-2180 (Pubitemid 351831532)
28. Cooper DS, Doherty GM, Haugen BR, Hauger BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214
29. Rieu M, Lame MC, Richard A, Lissak B, Sambort B, Vuong-Ngoc P, Berrod JL, Fombeur JP 1995 Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules. Clin Endocrinol (Oxf) 42:453-460
30. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, Vitti P 2010 American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: Executive Summary of Recommendations. J Endocrinol Invest 33:287-291
31. Hahm JR, Lee MS, Min YK, Lee MK, Kim KW, Nam SJ, Yang JH, Chung JH 2001 Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases. Thyroid 11:73-80 (Pubitemid 32140448)
32. Pacini F, Fontanelli M, Fugazzola L, Elisei R, Romei C, Di Coscio G, Miccoli P, Pinchera A 1994 Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 78:826-829 (Pubitemid 24118072)
33. Ozgen AG, Hamulu F, Bayraktar F, Yilmaz C, Tüzün M, Yetkin E, Tunçyürek M, Kabalak T 1999 Evaluation of routine basal serum calcitonin measurement for early diagnosis of medullary thyroid carcinoma in seven hundred seventy-three patients with nodular goiter. Thyroid 9:579-582 (Pubitemid 29296120)
34. Machens A, Hoffmann F, Sekulla C, Dralle H 2009 Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer. Endocr Relat Cancer 16:1291-1298
35. Toledo SP, Lourenço Jr DM, Santos MA, Tavares MR, Toledo RA, Correia-Deur JE 2009 Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma. Clinics (Sao Paulo) 64:699-706
36. Doyle P, Düren C, Nerlich K, Verburg FA, Grelle I, Jahn H, Fassnacht M, Mäder U, Reiners C, Luster M 2009 Potency and tolerance of calcitonin stimulation with high-dose calcium versus pentagastrin in normal adults. J Clin Endocrinol Metab 94:2970-2974
37. Colombo C, Verga U, Perrino M, Vicentini L, Beck-Peccoz P, Fugazzola L 2010 High-dose calcium and pentagastrin tests in patients with cured or persistent medullary thyroid cancer and in controls: comparison of the efficacy and the tolerance. Proc 14th Annual International Thyroid Congress, Paris, 2010 (Abstract P-0923)
38. Bugalho MJ, Mendonça E, Sobrinho LG 2000 Medullary thyroid carcinoma: an accurate pre-operative diagnosis by reverse transcription- PCR. Eur J Endocrinol 143:335-338
39. Takano T, Miyauchi A, Matsuzuka F, Liu G, Higashiyama T, Yokozawa T, Kuma K, Amino N 1999 Preoperative diagnosis of medullary thyroid carcinoma by RT-PCR using RNA extracted from leftover cells within a needle used for fine needle aspiration biopsy. J Clin Endocrinol Metab 84:951-955 (Pubitemid 29138224)
40. Diehl F, Schmidt K, Choti MA, Romans K, Goodman S, Li M, Thornton K, Agrawal N, Sokoll L, Szabo SA, Kinzler KW, Vogelstein B, Diaz Jr LA 2008 Circulating mutant DNA to assess tumor dynamics. Nat Med 14:985-990
41. Mazzaferri EL, Jhiang SM 1994 Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418-428
42. Machens A, Schneyer U, Holzhausen HJ, Dralle H 2005 Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level. J Clin Endocrinol Metab 90:2029-2034 (Pubitemid 40586235)
43. Scollo C, Baudin E, Travagli JP, Caillou B, Bellon N, Leboulleux S, Schlumberger M 2003 Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab 88:2070-2075 (Pubitemid 36549878)
44. Atli M, Akgul M, Saryal M, Daglar G, Yasti AC, Kama NA 2006 Thyroid incidentalomas: prediction of malignancy and management. Int Surg 91:237-244 (Pubitemid 44966756)
45. Bertazzo S, Turioni G, Ghimenton F, Toniolo L, Borsato N 1981 [Thyroid nodular pathology: retrospective study of 917 surgical interventions]. Chir Ital 33:852-863
46. Cerci C, Cerci SS, Eroglu E, Dede M, Kapucuoglu N, Yildiz M, Bulbul M 2007 Thyroid cancer in toxic and non-toxic multinodular goiter. J Postgrad Med 53:157-160 (Pubitemid 47281968)
47. Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M, Torlontano M, Filetti S 2007 Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 92:450-455
48. Fernando R, Mettananda DS, Kariyakarawana L 2009 Incidental occult carcinomas in total thyroidectomy for benign diseases of the thyroid. Ceylon Med J 54:4-6
49. Gandolfi PP, Frisina A, Raffa M, Renda F, Rocchetti O, Ruggeri C, Tombolini A 2004 The incidence of thyroid carcinoma in multinodular goiter: retrospective analysis. Acta Biomed 75: 114-117
50. Pelizzo MR, Toniato A, Piotto A, Bernante P 1996 [Cancer in multinodular goiter]. Ann Ital Chir 67:351-356
51. Pezzolla A, Docimo G, Ruggiero R, Monacelli M, Cirocchi R, Parmeggiani D, Conzo G, Gubitosi A, Lattarulo S, Ciampolillo A, Avenia N, Docimo L, PalascianoN2010 [Incidental thyroid carcinoma: a multicentric experience]. Recenti Prog Med 101:194-198
52. Tezelman S, Borucu I, Senyurek Giles Y, Tunca F, TerziogluT2009 The change in surgical practice from subtotal to near-total or total thyroidectomy in the treatment of patients with benign multinodular goiter. World J Surg 33:400-405
53. Chang TC, Wu SL, Hsiao YL 2005 Medullary thyroid carcinoma: pitfalls in diagnosis by fine needle aspiration cytology and relationship of cytomorphology to RET proto-oncogene mutations. Acta Cytol 49:477-482
54. Bugalho MJ, Santos JR, Sobrinho L 2005 Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement. J Surg Oncol 91:56-60 (Pubitemid 40967381)